Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP Severe COVID-19
NCT04634799Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of TM5614 in coronavirus disease 2019 (COVID-19), sponsored by Northwestern University. Started Jan 2021; status: terminated.
02
Drugs
TM5614
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04634799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04634799.